SCHEDULE: BiomX Inc. Stakeholder Discloses 20.4% Ownership

An amendment to a Schedule 13D filing reveals that Menachem Shalom, along with affiliated entities, now beneficially owns 20.4% of BiomX Inc. common stock following a business acquisition.

Summary

• This filing is an amendment to a previous Schedule 13D, updating information regarding beneficial ownership of BiomX Inc. common stock.
• Water IO Ltd., Star 26 Capital Inc., and T3 Defense Inc. are reporting entities, with Menachem Shalom identified as a key individual.
• Water IO Ltd. acquired 1,300,000 shares of BiomX Inc. common stock as consideration for the sale of its subsidiary, Zorronet, on April 10, 2026.
• Menachem Shalom personally acquired 300,000 shares of BiomX Inc. common stock in two separate transactions for $5.00 and $6.00 per share, funded by personal savings.
• Collectively, the reporting persons hold a significant stake: Water IO, Star 26 Capital, and T3 Defense each hold 1,300,000 shares (16.57% on a fully-diluted basis).
• Menachem Shalom beneficially owns 1,600,000 shares, representing 20.4% of the class on a fully-diluted basis.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports changes in beneficial ownership resulting from a business acquisition and personal investments, rather than performance-based results.

Positives

• The acquisition of Zorronet by BiomX Inc. is a strategic move that has resulted in a significant equity stake for Water IO Ltd.
• Menachem Shalom's personal investment in BiomX Inc. demonstrates confidence in the company.
• The reporting persons collectively hold a substantial percentage (20.4%) of BiomX Inc. shares, indicating significant influence or interest.

Negatives

• The filing does not detail any negative financial performance or operational issues for BiomX Inc. itself, focusing primarily on ownership changes.

Risks

• Potential for increased scrutiny from regulatory bodies due to significant ownership stakes.
• The concentration of ownership could lead to potential conflicts of interest or influence over corporate decisions.
• Future strategic decisions of BiomX Inc. may be heavily influenced by the objectives of these significant shareholders.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from BiomX Inc. management. It focuses on reporting changes in beneficial ownership.

Management Comments

• Menachem Shalom, CEO and director of T3 Defense Inc., signed the filings on behalf of Water IO Ltd., Star 26 Capital Inc., T3 Defense Inc., and himself.
• The acquisition of Zorronet by BiomX Inc. was part of a Stock Purchase Agreement dated April 10, 2026, where Water IO Ltd. received 1,300,000 shares of Common Stock and a $1,250,000 promissory note.

Industry Context

StockSavvy.ai notes that significant ownership changes reported via Schedule 13D filings are common in the biotechnology and defense sectors, often signaling strategic shifts or potential activist investor involvement. The involvement of entities like T3 Defense Inc., focused on mission-critical defense businesses, alongside Water IO Ltd.'s technology focus, suggests a potential diversification or integration strategy for BiomX Inc.

Related Party Transactions

• Water IO Ltd. sold 100% of the issued and outstanding share capital of Zorronet to BiomX Inc. for shares and a promissory note.

Stakeholder Impact

• Shareholders: Potential for increased volatility or strategic shifts in the company's direction due to significant ownership concentration.
• Management: May face increased influence or scrutiny from the new major shareholders.
• Creditors: The financial health of BiomX Inc. will be indirectly impacted by strategic decisions influenced by major shareholders.

Next Steps

• Monitor future filings from BiomX Inc. and the reporting persons for any further changes in beneficial ownership or strategic actions.
• Observe how the increased ownership stake influences BiomX Inc.'s corporate strategy and decision-making.

Key Dates

Recommendation

The filing indicates a significant shift in ownership concentration but does not provide performance data or strategic guidance from BiomX Inc. itself. While the increased stake by Menachem Shalom and associated entities suggests strong interest, a 'hold' recommendation is appropriate pending further information on the strategic implications and BiomX Inc.'s operational performance.

Keywords

BiomX Inc., Schedule 13D, Beneficial Ownership, Water IO Ltd., T3 Defense Inc., Star 26 Capital Inc., Menachem Shalom, Stock Acquisition, SEC Filing, Common Stock